Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

526 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of subgroups of patients with type 2 diabetes with differences in renal function preservation, comparing patients receiving sodium-glucose co-transporter-2 inhibitors with those receiving dipeptidyl peptidase-4 inhibitors, using a supervised machine-learning algorithm (PROFILE study): A retrospective analysis of a Japanese commercial medical database.
Zhou FL, Watada H, Tajima Y, Berthelot M, Kang D, Esnault C, Shuto Y, Maegawa H, Koya D. Zhou FL, et al. Among authors: watada h. Diabetes Obes Metab. 2019 Aug;21(8):1925-1934. doi: 10.1111/dom.13753. Epub 2019 Jun 3. Diabetes Obes Metab. 2019. PMID: 31050099 Free PMC article.
Reduction of insulin-stimulated glucose uptake by peroxynitrite is concurrent with tyrosine nitration of insulin receptor substrate-1.
Nomiyama T, Igarashi Y, Taka H, Mineki R, Uchida T, Ogihara T, Choi JB, Uchino H, Tanaka Y, Maegawa H, Kashiwagi A, Murayama K, Kawamori R, Watada H. Nomiyama T, et al. Among authors: watada h. Biochem Biophys Res Commun. 2004 Jul 30;320(3):639-47. doi: 10.1016/j.bbrc.2004.06.019. Biochem Biophys Res Commun. 2004. PMID: 15240096
Effect of sulfonylureas on switching to insulin therapy (twice-daily biphasic insulin aspart 30): comparison of twice-daily biphasic insulin aspart 30 with or without glimepiride in type 2 diabetic patients poorly controlled with sub-maximal glimepiride.
Ebato C, Shimizu T, Arakawa M, Mita T, Fujitani Y, Watada H, Kawamori R, Hirose T. Ebato C, et al. Among authors: watada h. Diabetes Res Clin Pract. 2009 Oct;86(1):31-6. doi: 10.1016/j.diabres.2009.07.008. Epub 2009 Aug 18. Diabetes Res Clin Pract. 2009. PMID: 19692134 Clinical Trial.
Transforming growth factor β1 T868C gene polymorphism is associated with cerebral infarction in Japanese patients with type 2 diabetes.
Katakami N, Kaneto H, Osonoi T, Kawai K, Ishibashi F, Imamura K, Maegawa H, Kashiwagi A, Watada H, Kawamori R, Shimomura I, Yamasaki Y. Katakami N, et al. Among authors: watada h. Diabetes Res Clin Pract. 2011 Dec;94(3):e57-60. doi: 10.1016/j.diabres.2011.08.005. Epub 2011 Aug 31. Diabetes Res Clin Pract. 2011. PMID: 21885147
Linagliptin monotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator-controlled, double-blind study.
Kawamori R, Inagaki N, Araki E, Watada H, Hayashi N, Horie Y, Sarashina A, Gong Y, von Eynatten M, Woerle HJ, Dugi KA. Kawamori R, et al. Among authors: watada h. Diabetes Obes Metab. 2012 Apr;14(4):348-57. doi: 10.1111/j.1463-1326.2011.01545.x. Epub 2012 Jan 17. Diabetes Obes Metab. 2012. PMID: 22145698 Clinical Trial.
A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations.
Imamura M, Maeda S, Yamauchi T, Hara K, Yasuda K, Morizono T, Takahashi A, Horikoshi M, Nakamura M, Fujita H, Tsunoda T, Kubo M, Watada H, Maegawa H, Okada-Iwabu M, Iwabu M, Shojima N, Ohshige T, Omori S, Iwata M, Hirose H, Kaku K, Ito C, Tanaka Y, Tobe K, Kashiwagi A, Kawamori R, Kasuga M, Kamatani N; Diabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium; Nakamura Y, Kadowaki T. Imamura M, et al. Among authors: watada h. Hum Mol Genet. 2012 Jul 1;21(13):3042-9. doi: 10.1093/hmg/dds113. Epub 2012 Mar 28. Hum Mol Genet. 2012. PMID: 22456796
[Sodium glucose cotransporter inhibitors].
Ikeda F, Watada H. Ikeda F, et al. Among authors: watada h. Nihon Rinsho. 2012 May;70 Suppl 3:716-20. Nihon Rinsho. 2012. PMID: 22768604 Japanese. No abstract available.
526 results